Health

Vancouver’s M Pharma (MQ) has a Novel Weight-Loss Drug that Actually Works

January 5, 2017

•

2 min read

M Pharma (MPHMF) M Pharma trades on the Canadian Securities Exchange (CSE) under the ticker symbol “MQ” as well as on the OTCQB as “MPHMF” and FWB (Frankfurt Stock Exchange) as “T3F2.”

The company is a Vancouver-based drug treatment and biomedical tech creating solutions for those with obesity, infertility and intimacy issues. The company has the exclusive rights to the obesity drug C-103, a reformulation of Orlistat, in both prescription strength and over the counter formulations. Our company has also secured the exclusive rights for a women’s health product to treat infertility called ToConceive. In addition, M Pharmaceutical holds the rights to Trimeo Weight Loss Capsules, an obesity management technology deploying temporary controllable pseudobezoars, an innovative method for non-invasive dynamic gastric volume reduction for weight loss that has been recently tested in blind, placebo-controlled human studies. The company was originally only intending to enter into the weight loss sector, but decided to expand last year to help develop safe and effective drugs.

The company’s obesity drug is a new version of the FDA-approved and best-selling Orlistat weight loss drug. The difference is C-103 is:

Orlistat is not an amphetamine
Orlistat does not affect the central nervous system
Orlistat is not systemically absorbed
Orlistat is the only FDA-approved OTC weight loss drug because of its safety
Orlistat is the only FDA-approved weight loss drug for adolescent patients (age 12-18)

Orlistat’s design is to keep the body from absorbing fat, but patients experienced uncomfortable gas and diarrhea. The C-103 product essentially removes this effect in 98% of cases.

The company’s second product is the infertility treatment proven to increase a women’s natural production of transudate (sexual lubrication). This increase in natural transudate is required for successful “Sperm Capacitation” to occur. Without the process of Sperm Capacitation, the sperm would not have the ability to travel the required distance to the ovum or have the appropriate chemical makeup for successful conception to occur. The product is patent-protected and is marketed toward couples with infertility issues.